A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Active, not recruiting · Phase 3 · NCT06315322
Conditions: Childhood Absence Epilepsy, Juvenile Absence Epilepsy
At a glance
- Research payments reported, 2025
- $242,900
- U.S. investigators named
- 6
- Sites paid
- 6
- Planned or actual enrollment
- 70
About the trial
- Sponsor
- UCB Biopharma SRL
- Tested
- Brivaracetam Film-coated tablet (drug), Brivaracetam oral solution (drug)
- Dates
- Started 2024-07-10; completion 2029-11-16
- Results posted
- Not yet
The purpose of the study is to investigate the long-term safety and tolerability of brivaracetam in study participants with childhood absence epilepsy or juvenile absence epilepsy.
From ClinicalTrials.gov, last updated 2026-08-27. Full record, eligibility and contacts (opens in a new tab)
Industry funding
UCB SA reported $242,900 in research payments for this study in 2025 (6 payments).
Products named: Briviact
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Pongkiat Kankirawatana, M.D. Child Neurology · Birmingham, AL
- Donald J. Phillips, M.D. Neurology · Orange, CA
- Anuj Jayakar, MD Child Neurology · Miami, FL
- Yong D. Park, MD Child Neurology · Augusta, GA
- Gautam S. Popli, M.D. Child Neurology · Winston Salem, NC
- Carlos Lastra, M.D. Child Neurology · New Brunswick, NJ
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- University of Alabama Hospital, AL $157,471
- Children's Hospital of Orange County, CA $24,795
- Nicklaus Children's Hospital, FL $23,638
- Wake Forest University Health Sciences $21,313
- Augusta University Research Inst. Inc. $9,375
- Saint Peter's University Hospital, NJ $6,308
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.